首页> 外文期刊>Journal of Medical Imaging and Health Informatics >Long-Term Assessment of the Quality of Visually-Related Daily Activities After ICL (V4c) Implantation for Myopia and Myopic Astigmatism
【24h】

Long-Term Assessment of the Quality of Visually-Related Daily Activities After ICL (V4c) Implantation for Myopia and Myopic Astigmatism

机译:在ICL(V4C)植入近视和近视散光后的视觉相关日常活动质量的长期评估

获取原文
获取原文并翻译 | 示例
       

摘要

This study was performed to evaluate the long-term quality of visually related daily activities after Central Hole Collamer Lens Implantation to treat myopia and astigmatism. This study included 46 eyes (in 23 patients) that received ICL-V4c implantation. The follow up time was at least 24 months. Moreover, patient satisfaction related to daily vision activities were recorded at 6 and 24 months. The parameters measured included uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), refraction, eye axis, intraocular pressure (IOP), endothelial cell density (ECD) and vault. The mean spherical equivalents were -0.14 +/- 0.21 D and -0.12 +/- 0.33 D at 6 and 24 months after surgery, respectively. All the eyes were better postoperative (UCVA) than preoperative (BCVA). The BCVA at 6 and 24 months after implantation was -0.03 +/- 0.08 LogMAR and -0.03 +/- 0.11 LogMAR, which is statistically better (P = 0.031) than the pre-operation value 0.07 +/- 0.12 LogMAR. There was no significant (P > 0.05) difference between the pre-operation and post-operation ECD. At 24 months post-operation, 10% of the patients complained about difficulty driving at night; meanwhile, most patients expressed satisfaction or were very satisfied. Approximately 13% of the patients worried about long term safety and efficacy after the ICL-V4c implantation. Patients are very satisfied with daily related vision activities after ICL-V4c implantation.
机译:该研究进行了评估中央孔溶液植入后视觉相关日常活动的长期质量,以治疗近视和散光。本研究包括46只眼(23名患者),接受ICL-V4C植入。后续时间至少为24个月。此外,与日常视觉活动相关的患者满意度在6和24个月内记录。测量的参数包括未经校正的视力(UCVA),最佳校正的视力(BCVA),折射,眼轴,眼内压(IOP),内皮细胞密度(ECD)和拱顶。平均球形当量分别为-0.14 +/- 0.21d和-0.12 +/- 0.33d,分别在手术后6和24个月。所有的眼睛都比术前(UCVA)更好,而不是术前(BCVA)。植入后6和24个月的BCVA为-0.03 +/- 0.08 logmar和-0.03 +/- 0.11 Logmar,其比预操作值0.07 +/- 0.12 Logmar更好(P = 0.031)。操作前和操作后ECD之间没有显着(p> 0.05)差异。在运营后24个月,10%的患者抱怨晚上驾驶困难;同时,大多数患者表达满意或非常满意。大约13%的患者担心ICL-V4C植入后的长期安全性和疗效。在ICL-V4C植入后,患者对日常相关视觉活动非常满意。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号